Asymmetric synthesis of phorboxazole B - Part I: Synthesis of the C20-C38 and C39-C46 subunits

Angewandte Chemie - International Edition

Volumn 39, Issue 14, 2000, Pages 2533-2536

  Evans, David A ^a   Cee, Victor J ^a   Smith, Thomas E ^a   Fitch, Duke M ^a   Cho, Patricia S ^a  

^a HARVARD UNIVERSITY   (United States)

Author keywords

Aldol reactions; Antitumor agents; Macrolides; Natural products; Total synthesis

Indexed keywords

PHORBOXAZOLE B;

ANTINEOPLASTIC ACTIVITY; ARTICLE; CYTOSTASIS; DRUG SYNTHESIS; MOLECULAR INTERACTION; SPONGE (PORIFERA);

EID: 0034679519     PISSN: 14337851     EISSN: None     Source Type: Journal    
DOI: 10.1002/1521-3773(20000717)39:14<2533::AID-ANIE2533>3.0.CO;2-B     Document Type: Article

References (61)

1. Isolation and structure elucidation: a) P. A. Searle, T. F. Molinski, J. Am. Chem. Soc. 1995, 117, 8126-8131;
2. b) P. A. Searle, T. K. Molinski, L. J. Brzezinski, J. W. Leahy, J. Am. Chem. Soc. 1996, 118, 9422-9423;
3. c) T. F. Molinski, Tetrahedron Lett. 1996, 37, 7879-7880.
4. 50 is defined as the concentration at which cell growth is inhibited by 50%. See ref. [1a] and [1b]. Phorboxazoles A and B display comparable biological activities, see ref. [1a].
5. Phorboxazole synthetic studies: a) S. D. Rychnovsky, C. R. Thomas, Org. Lett. 2000, 2, 1217-1214;
6. b) G. Pattenden, A. T. Plowright, Tetrahedron Lett. 2000, 41, 983-986;
7. c) J. V. Schaus, J. S. Panek, Org. Lett. 2000, 2, 469-471;
8. d) P. Wolbers, H. M. R. Hoffmann, F. Sasse, Synlett 1999, 11, 1808-1810;
9. e) A. B. Smith III, P. R. Verhoest, K. P. Minbiole, J. J. Lim, Org. Lett. 1999, 1, 909-912;
10. f) A. B. Smith III, K. P. Minbiole, P. R. Verhoest, T. J. Beauchamp, Org. Lett. 1999, 1, 913-916;
11. g) P. Wolbers, A. M. Misske, H. M. R. Hoffmann, Tetrahedron Lett. 1999, 40, 4527-4530;
12. h) D. A. Evans, V. J. Cee, T. H. Smith, K. J. Santiago, Org. Lett. 1999, 1, 87-90;
13. i) P. Wolbers, H. M. R. Hoffmann, Synthesis 1999, 5, 797-802;
14. j) A. M. Misske, H. M. R. Hoffmann, Tetrahedron 1999, 55, 4315-5324;
15. k) D. R. Williams, M. P. Clark, Tetrahedron Lett. 1999, 411, 2291-2294;
16. l) D. R. Williams, M. P. Clark, M. A. Berliner, Tetrahedron Lett. 1999, 40, 2287-2290;
17. m) P. Wolbers, H. M. R. Hoffmann, Tetrahedron 1999, 55, 1905-1914;
18. n) S. D. Rychnovsky, Y. Hu, B. Ellsworth, Tetrahedron Lett. 1998, 39, 7271-7274;
19. o) I. Paterson, E. A. Arnott, Tetrahedron Lett. 1998, 39, 7185-7188;
20. p) G. Pattenden, A. T. Plowright, J. A. Tornos, T. Ye, Tetrahedron Lett. 1998, 39, 6099-6102;
21. q) T. Ye, G. Pattenden, Tetrahedron Lett. 1998, 39, 319-322;
22. r) F. Ahmed, C. J. Forsyth, Tetrahedron Lett. 1998, 39, 183-186;
23. s) R. D. Cink, C. J. Forsyth, J. Org. Chem. 1997, 62, 5672-5673;
24. t) C. S. Lee, C. J. Forsyth, Tetrahedron Lett. 1996, 37, 6449-6452;
25. u) total synthesis of phorboxazole A: C. J. Forsyth, F. Ahmed, R. D. Cink, C. S. Lee, J. Am. Chem. Soc. 1998, 120, 5597-5598.
26. D. A. Evans, D. M. Fitch, Angew. Chem. 2000, 112, 2636-2640; Angew. Chem. Int. Ed. 2000, 39, 2536-2540.
27. D. A. Evans, D. M. Fitch, Angew. Chem. 2000, 112, 2636-2640; Angew. Chem. Int. Ed. 2000, 39, 2536-2540.
28. Abbreviations: dr=diastereomer ratio; TES=triethylsilyl; TPS= triphenylsilyl; TIPS=triisopropylsilyl; Ms=methanesulfonyl; Bn= benzyl; TMS=trimethylsilyl; DBU=1,8-diazabicyclo[5.4.0]undec-7-ene; DMF=N,N-dimethylformamide; DMAP=N,N-dimethylaminopyridine; LDA=lithium diisopropylamide; TMP=2,2,6,6-tetramethylpiperidide; NBS=N-bromosuccinimide; Tr=trityl=triphenylmethyl; Ts=para-toluenesulfonyl; DIAD=diisopropylazodicarboxylate; THF=tetrahydrofuran; HMDS=hexamethyldisilazide; pyr=pyridine; TEA=triethylamine; DMSO=dimethyl sulfoxide; Tf=triflate=trifluoromethanesulfonyl.
29. D. A. Evans, M. C. Kozlowski, J. A. Murry, C. S. Burgey, K. R. Campos, B. T. Connell, R. J. Staples, J. Am. Chem. Soc. 1999, 121, 669-685.
30. D. A. Evans, M. D. Ennis, T. Le, N. Mandel, G. Mandel, J. Am. Chem. Soc. 1984, 106, 1154-1156.
31. a) D. L. Boger, T. T. Curran, J. Org. Chem. 1992, 57, 2235-2244;
32. b) D. P. Provencal, C. Gardelli, J. A. Lafontaine, J. W. Leahy, Tetrahedron Lett. 1995, 36, 6033-6036.
33. 1 major=14.9min).
34. For examples of β-ketoimide aldol reactions, see a) D. A. Evans, H. P. Ng, J. S. Clark, D. L. Rieger, Tetrahedron 1992, 48, 2127-2142;
35. b) D. A. Evans, H. P. Ng, D. L. Rieger, J. Am. Chem. Soc. 1993, 115, 11446-11459.
36. D. A. Evans, K. T. Chapman, E. M. Carreira, J. Am. Chem. Soc. 1988, 110, 3560-3578.
37. 1H NMR analysis (500 MHz).
38. M. D. Lewis, J. K. Cha, Y. Kishi, J. Am. Chem. Soc. 1982, 104, 4976-4978.
39. For similar conditions employing ethylene glycol in place of methanol, see a) T. H. Chan, M. A. Brook, T. Chaly, Synthesis 1983, 203-205; b) ref. [4].
40. For similar conditions employing ethylene glycol in place of methanol, see a) T. H. Chan, M. A. Brook, T. Chaly, Synthesis 1983, 203-205; b) ref. [4].
41. For a related reduction with Raney-Ni, see R. Bacardit, M. Moreno-Mañas, Tetrahedron Lett. 1980, 21, 551-554.
42. For reports of oxazole lithiation, see ref. [3h], and references therein.
43. A. B. Smith III, S. M. Cordon, J. A. McCauley, J. L. Leazer, Jr., J. W. Leahy, R. E. Maleczka, Jr., J. Am. Chem. Soc. 1997, 119, 962-973; A. B. Smith III, S. M. Condon, J. A. McCauley, J. L. Leazer, Jr., J. W. Leahy, R. E. Maleczka, Jr., J. Am. Chem. Soc. 1995, 117, 5407-5408.
44. A. B. Smith III, S. M. Cordon, J. A. McCauley, J. L. Leazer, Jr., J. W. Leahy, R. E. Maleczka, Jr., J. Am. Chem. Soc. 1997, 119, 962-973; A. B. Smith III, S. M. Condon, J. A. McCauley, J. L. Leazer, Jr., J. W. Leahy, R. E. Maleczka, Jr., J. Am. Chem. Soc. 1995, 117, 5407-5408.
45. Conditions were adapted from: C. H. Heathcock, S. D. Young, J. P. Hagen, R. Pilli, U. Badertscher, J. Org. Chem. 1985, 50, 2095-2105.
46. D. B. Dess, J. C. Martin, J. Am. Chem. Soc. 1991, 113, 7277-7287.
47. (R)-3-(triphenylmethyl)-1,2-epoxypropane is commercially available from Aldrich Chemical Co. and may also be prepared in 95% ee by Sharpless asymmetric epoxidation of allyl alcohol and in situ tritylation. Recrystallization provides the enantiomerically enriched compound: H. S. Hendrickson, E. K. Hendrickson, Chem. Phys. Lipids 1990, 53, 115-120.
48. 2-promoted organolithium additions to epoxides, see c) M. J. Eis, J. E. Wrobel, B. Ganem, J. Am. Chem. Soc. 1984, 106, 3693-3694.
49. 2-promoted organolithium additions to epoxides, see c) M. J. Eis, J. E. Wrobel, B. Ganem, J. Am. Chem. Soc. 1984, 106, 3693-3694.
50. 2-promoted organolithium additions to epoxides, see c) M. J. Eis, J. E. Wrobel, B. Ganem, J. Am. Chem. Soc. 1984, 106, 3693-3694.
51. Conditions were adapted from: R. Bellingham, K. Jarowicki, P. Kocienski, V. Martin, Synthesis 1996, 285-296.
52. Conditions were adapted from: ref. [3p]. For the synthesis of (E)-3-iodo-2-methylprop-2-enal, see R. Baker, J. L. Castro, J. Chem. Soc. Perkin Trans. 1 1990, 47-65.
53. J. R. Parikh, W. E. von Doering, J. Am. Chem. Soc. 1967, 89, 5505-5507.
54. M. T. Reetz, Angew. Chem. 1984, 96, 542-555; Angew. Chem. Int. Ed. Engl. 1984, 23, 556-569.
55. M. T. Reetz, Angew. Chem. 1984, 96, 542-555; Angew. Chem. Int. Ed. Engl. 1984, 23, 556-569.
56. 1H NMR spectroscopy.
57. We are aware of few examples of this type of selective lithium-halogen exchange reaction. For a report involving bishalogenated arenes, see M. Kihara, M. Kashimoto, Y. Kohayashi, Tetrahedron 1992, 48, 67-78.
58. For an example of a chelation-controlled zincate addition, see D. R. Williams, W. S. Kissel, J. Am. Chem. Soc. 1998, 120, 11198-11199.
59. For an example of a chelation-controlled aluminate addition, see H. Imogai, Y. Petit, M. Larcheveque, Tetrahedron Lett. 1996, 37, 2573-2576.
60. A similar solvent effect has been noted in additions of alkenyl Grignard reagents to α-alkoxyaldehydes: G. E. Keck, M. A. Andrus, D. R. Romer, J. Org. Chem. 1991, 56, 417-420.
61. 2O/benzene, see M. Nakatsuka, J. A. Ragan, T. Sammakia, D. B. Smith, D. E. Uehling, S. L. Schreiber, J. Am. Chem. Soc. 1990, 112, 5583-5601.